Novel heterologous listeria-adenovirus mucosal vaccine for HIV-1
Novel heterologous listeria-adenovirus mucosal vaccine for HIV-1
批准号:
7915872
负责人:
Fred Robert Frankel
金额:
$80.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-17 至 2011-08-31
关键词:
AIDS VaccinesAIDS vaccine developmentAbsence of pain sensationAcquired Immunodeficiency SyndromeAddressAdenovirus VectorAdenovirusesAdjuvantAffectAfricaAgreementAlcoholsAliquotAmendmentAnalgesicsAnesthesia proceduresAnestheticsAnimal Care and Use CommitteesAnimal ExperimentationAnimal ExperimentsAnimal FeedAnimal HousingAnimal ModelAnimal Use AlternativesAnimal WelfareAnimal Welfare ActAnimalsAnorexiaAntibioticsAntibody FormationAntigensAnusApplications GrantsAppointmentAreaAscitesAttenuatedAuthorization documentationAwardAxillaBackBacteriaBandageBathingBehaviorBehavior ControlBiologicalBiological AssayBiomedical ResearchBiopsyBiopsy SpecimenBirdsBloodBlood VesselsBlood specimenBody FluidsBody WeightBody Weight decreasedBostonBoxingBreedingBronchiBronchoalveolar LavageBronchoscopesBudgetsBuprenexBuprenorphineBurn injuryBusinessesCalendarCapsidCardiacCaringCategoriesCathetersCause of DeathCellsCellular ImmunityCellular ImmunologyCertificationCervicalCervix UteriCessation of lifeChairpersonChildhoodClinicalClinical ResearchClinical TrialsCollaborationsCollectionColorectalCommitCommittee MembersCommunicationComplement component C1sConfidential InformationConsultConsultationsCountryCulture MediaDNADNA VaccinesDNA vaccine-elicited immunityDataDevelopmentDevicesDiarrheaDietDirect CostsDisclosureDiseaseDissectionDistressDoctor of PhilosophyDorsalDoseDrug FormulationsDuct (organ) structureDuodenumEducational process of instructingEffectivenessElectrodesElectronic MailElectronicsElectroporationEmployeeEndoscopesEndoscopic BiopsyEngineeringEpidemicEquipmentEuthanasiaEventExcisionExerciseExhibitsExperimental Water DeprivationFaceFacilities and Administrative CostsFacultyFailureFastingFellowshipFemoral veinFlow CytometryFlushingFoodForcepFormalinFoundationsFrequenciesFringe BenefitFundingFunding AgencyGenital systemGenotypeGenus MycobacteriumGoalsGoldGovernmentGrantGuidelinesHIVHIV AntigensHIV InfectionsHIV vaccineHIV-1HIV-1 vaccineHIV/SIV vaccineHandHeadHealth InsuranceHealth PrioritiesHemorrhageHemostatic functionHeterosexualsHistopathologyHome environmentHourHousingHumanHuman ResourcesHybridomasIACUCIceImageImmuneImmune responseImmune systemImmunityImmunizationImmunologyImmunology procedureImpairmentIn VitroIncomeIndividualInfantInfectionInjection of therapeutic agentInjuryInpatientsInstitutesInstitutionInstructionIntraperitoneal InjectionsInvestmentsIrrigationIsraelJapanKetamineKetamine HydrochlorideKnock-outLaboratoriesLaboratory AnimalsLanguageLaryngoscopesLarynxLateralLawsLeadLeftLettersLidocaineLifeLife Cycle StagesLightLiquid substanceListeriaListeria monocytogenesLiteratureLocationLungLymphocyteMacaca mulattaMagnetic Resonance ImagingMailsMaintenanceManualsMarketingMediationMedicalMedical centerMedicineMethodsMicrobiologyMinorModelingModificationMolecularMolecular BiologyMolecular ConformationMonitorMonkeysMucosal Immune ResponsesMucosal ImmunityMucous MembraneMusMuscleNIH Vaccine Research CenterNamesNational Institute of Allergy and Infectious DiseaseNatureNeedlesNeurologicORALITOperative Surgical ProceduresOpportunistic InfectionsOralOral mucous membrane structureOrganOutpatientsOvumPainParalysedPathogenesisPatient CarePelvisPennsylvaniaPeripheralPersonal SatisfactionPersonsPharmaceutical PreparationsPhase I Clinical TrialsPhenotypePhiladelphiaPhysiologic pulsePilot ProjectsPlasmaPlasticsPoisonPoliciesPoriferaPositioning AttributePostdoctoral FellowPostoperative PeriodPovidone-IodinePoxviridaePreparationPrimatesPrincipal InvestigatorPrintingProceduresProcessProductionProgress ReportsProteinsProtocols documentationPublic HealthQuarantineQuestionnairesRadioisotopesReadingReagentRecombinant DNARecombinant ProteinsRecombinantsRegulationRegulatory AffairsReportingResearchResearch PersonnelResearch SubjectsResearch SupportResponse ElementsRiotsRisk AssessmentRodentRoleRouteSIVSafetySalineSamplingScheduleSchoolsScienceScientistSerotypingServicesShockSignal TransductionSiteSkinSocietiesSonSourceSpecialistSpecimenSpeculumsSterilityStimulusStomachStructure of pyloric ostium of stomachSumSupervisionSurgical incisionsSyringesSystems BiologyT-LymphocyteTechniquesTechnologyTelazolTelefacsimileTelephoneTestingTimeTissue HarvestingTissue and Organ HarvestingTissuesToxinTracheaTrainingTranquilizing AgentsTransgenic MiceTransgenic OrganismsTraumaTravelTreatment ProtocolsTubeU-Series Cooperative AgreementsUnited States National Institutes of HealthUniversitiesUpdateUrineVaccinatedVaccinationVaccinesVaginaVariantVeinsVenipuncturesVeterinariansVicrylViralViral PathogenesisViral VectorVirusWagesWalkersWalkingWeightWitWomanWorkWritingabsorptionabstractinganimal careauthoritybasebehavior observationchemical carcinogenchiron vaccineclinical efficacyconformercostdesignenvironmental changeexperienceexpirationfeedingflexibilitygastrointestinalhuman subjectimmunogenicimmunogenicityimplantationimprovedin vivoinhibitor/antagonistinstrumentinterestintravenous injectionirradiationjejunumlymph nodesmedical schoolsmeetingsmicrobicidemicroorganismmucosal sitemucosal vaccinationmucosal vaccinenanoparticleneutralizing antibodynonhuman primatenovelnovel strategiespandemic diseasepathogenpediatric AIDSpediatric human immunodeficiency viruspeerpoxvirus vectorspre-clinicalpreclinical evaluationpreclinical studyprofessorprogramsprotective efficacypublic health relevancerectalresearch clinical testingresearch studyresponserestraintskillssymposiumtext searchingtissue culturetransmission processtumoruptakevaccine candidatevaccine deliveryvaccinologyvectorvector vaccinevector-based vaccineviral RNAvocal cordweb site
中文摘要
.项目总结/摘要
艾滋病仍然是一种不断扩大的流行病。研制成功
安全有效的艾滋病毒疫苗是一项全球卫生优先事项,
目前无法有效地将HIV抗原输送到免疫系统,
可预测的,高频率和持久的免疫反应。接近
针对这一问题,我们提出了一种独特的初免-加强疫苗策略,
粘膜载体,单核细胞增生李斯特菌(Listeria monocytogenes,Lm)和腺病毒(Ad),每种
它已经在人体临床试验中进行了测试,两者都显示出在
小动物模型和NHP以引发强细胞免疫。该提案
我们最近观察到粘膜给药减毒李斯特菌
随后用复制缺陷型Ad 5加强,
粘膜T细胞反应,并通过开发新的Ad变体,
抗Ad 5免疫因为大多数艾滋病毒感染是由异性性传播造成的
因为这种病毒的目标是肠道和阴道粘膜中的淋巴细胞,
为了迅速消灭这些病媒,本项目旨在利用这些病媒加强免疫力
并保护这些重要的粘膜部位。Dan Barouch博士的实验室
贝丝以色列女执事医疗中心和弗雷德弗兰克尔在大学
宾夕法尼亚医学院将合作探索潜在的协同作用,
这两个向量。弗兰克尔博士将在小鼠中研究载体的相互作用,
Barouch将同时进行试点研究,在非人类中测试这些载体。
灵长类动物模型
英文摘要
. Project Summary/Abstract
AIDS continues to be an expanding pandemic. The successful development of a
safe and effective HIV vaccine is a global health priority that has been hampered by our
current inability to deliver HIV antigens efficiently to the immune system to prime
predictable, high frequency, and durable immune responses in humans. To approach
this problem, we propose a unique prime-boost vaccine strategy that pairs two live
mucosal vectors, Listeria monocytogenes (Listeria, Lm) and adenovirus (Ad), each of
which has been tested in clinical trials in humans, and both have shown the ability in
small animal models and NHP to elicit strong cellular immunity. The proposal is
provoked by our recent observations that mucosal administration of attenuated Listeria
followed by a boost by replication-incompetent Ad5 elicited potent peripheral and
mucosal T cell responses, and by the development of new Ad variants that circumvent
anti-Ad5 immunity. Because most HIV infections result from heterosexual transmission
to women, and because the virus targets lymphocytes in the gut and vaginal mucosae
for rapid elimination, this project aims by use of these vectors to strengthen immunity
and protection at these important mucosal sites. The laboratories of Drs. Dan Barouch
at Beth Isreal Deaconess Medical Center and Fred Frankel at the University of
Pennsylvania School of Medicine will collaborate to explore the potential synergy of
these two vectors. Dr. Frankel will examine vector interactions in mice, while Dr.
Barouch will conduct concurrent pilot studies testing these vectors in the nonhuman
primate model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vaccine Production Core
-
批准号:7952753
-
项目类别:
-
资助金额:$8.9万
-
财政年份:2009
-
负责人:Fred Robert Frankel
-
依托单位:
Vaginal Immunity After Intranasal Listeria Vaccination
-
批准号:7933238
-
项目类别:
-
资助金额:$18.18万
-
财政年份:2007
-
负责人:Fred Robert Frankel
-
依托单位:
Vaginal Immunity After Intranasal Listeria Vaccination
-
批准号:7334102
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2007
-
负责人:Fred Robert Frankel
-
依托单位:
Vaginal Immunity After Intranasal Listeria Vaccination
-
批准号:7472543
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2007
-
负责人:Fred Robert Frankel
-
依托单位:
Optimizing Listeria for use as an HIV Vaccine
-
批准号:6511293
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2001
-
负责人:Fred Robert Frankel
-
依托单位:
Optizimizing Listeria for use as an HIV Vaccine
-
批准号:6346487
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2001
-
负责人:Fred Robert Frankel
-
依托单位:
SAFE VACCINE STRAIN OF LISTERIA MONOCYTOGENES FOR HIV
-
批准号:2649221
-
项目类别:
-
资助金额:$31.9万
-
财政年份:1998
-
负责人:Fred Robert Frankel
-
依托单位:
SAFE VACCINE STRAIN OF LISTERIA MONOCYTOGENES FOR HIV
-
批准号:6163938
-
项目类别:
-
资助金额:$32.11万
-
财政年份:1998
-
负责人:Fred Robert Frankel
-
依托单位:
A Safe Vaccine Strain of Listeria Monocytogenes for HIV
-
批准号:6494977
-
项目类别:
-
资助金额:$16.92万
-
财政年份:1998
-
负责人:Fred Robert Frankel
-
依托单位:
A Safe Vaccine Strain of Listeria Monocytogenes for HIV
-
批准号:6706359
-
项目类别:
-
资助金额:$35.9万
-
财政年份:1998
-
负责人:Fred Robert Frankel
-
依托单位:
A Safe Vaccine Strain of Listeria Monocytogenes for HIV
-
批准号:6862683
-
项目类别:
-
资助金额:$36.98万
-
财政年份:1998
-
负责人:Fred Robert Frankel
-
依托单位:
A Safe Vaccine Strain of Listeria Monocytogenes for HIV
-
批准号:6656968
-
项目类别:
-
资助金额:$34.86万
-
财政年份:1998
-
负责人:Fred Robert Frankel
-
依托单位:
SAFE VACCINE STRAIN OF LISTERIA MONOCYTOGENES FOR HIV
-
批准号:2882241
-
项目类别:
-
资助金额:$31.25万
-
财政年份:1998
-
负责人:Fred Robert Frankel
-
依托单位:
A Safe Vaccine Strain of Listeria Monocytogenes for HIV
-
批准号:7013653
-
项目类别:
-
资助金额:$37.19万
-
财政年份:1998
-
负责人:Fred Robert Frankel
-
依托单位:
STERIOD REGULATED EXPRESSION IN THE UTERUS
-
批准号:3153222
-
项目类别:
-
资助金额:$18.8万
-
财政年份:1984
-
负责人:Fred Robert Frankel
-
依托单位:
STERIOD REGULATED EXPRESSION IN THE UTERUS
-
批准号:3232898
-
项目类别:
-
资助金额:$17.93万
-
财政年份:1984
-
负责人:Fred Robert Frankel
-
依托单位:
海外基金